argenx BVBA (ARGX) - Uzoq muddatli qarzning kapitalga koeffitsiyenti

argenx BVBA - ARGX emitenti grafik logotipi

argenx SE (ARGX) o'zining biomeditsina tadqiqotlariga etika va ekologiyaga e'tibor qaratgan holda ESG tamoyillarini integratsiya qiladi. Operatsion model ishlab chiqarish va sinovlarning to'liq autsorsingiga tayanadi, bu esa kapital xarajatlarini minimallashtiradi. GURU.Markets platformasi grafigidagi tasdiqlangan narxlar tarixi, u yerda ko'rsatkich 0.00 hisoblanadi, Vyvgart dori vositasining ko'rsatmalari kengayishi orqali kam uchraydigan kasalliklarni davolash ekotizimining rivojlanishini to'ldiradi.

argenx N.V. (ARGX): Uzoq muddatli qarzning o'z kapitaliga nisbati 04.07.2022dan 30.10.2026gacha

argenx SE (ARGX) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- aksiya narxi va konsensus maqsadli narx:
Kotirovkalar grafigi argenx N.V.|ARGX - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi ko'rsatkichlari:
Bozor qiymati argenx SE|ARGX - Korxona qiymati
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
Bitta aksiya hisobiga balans qiymati argenx|ARGX - Kompaniyaning balans qiymati|Balans qiymatiga nisbatan bozor qiymati argenx.com|ARGX - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati argenx SE|ARGX - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati argenx.com|ARGX - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati argenx SE|ARGX - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi argenx|Tezkor likvidlik ko‘rsatkichi argenx.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
ARGX - Kompaniyaning sof foydasi
Kompaniyaning umumiy tahlili:argenx N.V. - ARGX
argenx SE brend mahsuloti

Investor uchun emitentning uzoq muddatli ishonchliligi qarz va kapital o'rtasidagi muvozanat bilan belgilanadi, bunda ushbu ko'rsatkich kapital tuzilmasidagi muddati bir yildan ortiq bo'lgan kreditlarning ulushini o'lchaydi. Uzoq muddatli qarzning kapitalga nisbatini tahlil qilish orqali WACC ning biznesni baholashga ta'sirini baholash mumkin, bu esa argenx SE (ARGX) holatida global savdo kengayishi davomida Tim Van Hauweriken jamoasining moliyaviy barqarorligini tasdiqlaydi.

Muhim raqobatchilar

BioNTech Inc. - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ABVX|ADMA (ADMA Corp) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati PTGX (Protagonist Therapeutics)|Uzoq muddatli qarzning kapitalga nisbati immunovant.com IMVT|KNSA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti GRFS (Grifols SA)|Adaptive Biotechnologies Corp (ADPT) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Celldex Corp|AUPH (Aurinia Pharmaceuticals) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati biocryst.com|Uzoq muddatli qarzning o'z kapitaliga nisbati VERA (Vera Therapeutics)|DNTH (Dianthus Therapeutics Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati PHVS (Pharvaris Corp)|Uzoq muddatli qarzdorlikning kapitalga nisbati AbCellera (ABCL)|TRML - Uzoq muddatli qarzning o'z kapitaliga nisbati|precigen.com (PGEN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Pharming Group (PHAR) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Nektar Therapeutics Inc|Uzoq muddatli qarzning o'z kapitaliga nisbati UPB|Uzoq muddatli qarzning kapitalga nisbati Zenas Corp|Uzoq muddatli qarzning o'z kapitaliga nisbati Immunome, Inc. (IMNM)|gossamerbio.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati KALV (KalVista Pharmaceuticals, Inc.)|Septerna, Inc. (SEPN) - Uzoq muddatli majburiyatlarning kapitalga nisbati|Pieris Pharmaceuticals Inc - Uzoq muddatli qarzning kapitalga nisbati|SVRA - Uzoq muddatli qarzning kapitalga nisbati|Rigel Pharmaceuticals (RIGL) - Uzoq muddatli qarzning o'z kapitaliga nisbati|anaptysbio.com - Uzoq muddatli qarzning kapitalga koeffitsiyenti|ATXS (Astria Therapeutics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|ENGN - Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati RAPT|JBIO - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Aclaris Therapeutics ACRS|KYTX: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|TLSA: Uzoq muddatli qarzning o'z kapitaliga nisbati|CABA (Cabaletta Bio Inc.) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|VTYX (Ventyx Bio) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Theratechnologies, Inc - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Avalo Therapeutics, Inc|eledon.com (ELDN) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati AGEN|CLYM - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati ZURA (Zura Bio Limited)|Uzoq muddatli qarzning kapitalga nisbati aTyr Pharmaceuticals ATYR|ADAG - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti IMA (ImageneBio Inc)|STTK: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati Equillium EQ|Uzoq muddatli qarzning o'z kapitaliga nisbati CNTB|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi IMUX (Immunic Inc)|Uzoq muddatli qarzning o'z kapitaliga nisbati Atara Biotherapeutics (ATRA)|IFRX: Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati XFOR (X4 Pharmaceuticals, Inc.)|Uzoq muddatli qarzning kapitalga koeffitsiyenti ACET|Celularity Corp - Uzoq muddatli qarzning kapitalga nisbati|INMB - Uzoq muddatli qarzning kapitalga nisbati|Barinthus Biotherapeutics (BRNS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|kezarlifesciences.com - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati SAB Biotherapeutics, Inc.|Uzoq muddatli qarzning o'z kapitaliga nisbati Akari Therapeutics PLC (AKTX)|Uzoq muddatli qarzning kapitalga nisbati ENLV|Uzoq muddatli qarzning kapitalga nisbati q32bio.com (QTTB)|GeoVax Labs, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti EDSA|iBio - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Carisma Therapeutics CARM|XTL Biopharmaceuticals, Ltd. (XTLB) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Bolt Biotherapeutics, Inc.|Uzoq muddatli qarzning o'z kapitaliga nisbati HCW Biologics, Inc.|Uzoq muddatli qarzning o'z kapitaliga nisbati Aptevo (APVO)|Uzoq muddatli qarzning o'z kapitaliga nisbati AIM (AIM ImmunoTech)|Uzoq muddatli qarzning kapitalga nisbati aditxt.com (ADTX)|Uzoq muddatli qarzning o'z kapitaliga nisbati GRI Bio Corp GRI|XRTX: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Vyome Holdings Inc - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati revbiosciences.com|INDP: Uzoq muddatli qarzning kapitalga nisbati|Scinai Immunotherapeutics Ltd (SCNI) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati CalciMedica Inc|AFMD: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ALLK|hookipapharma.com (HOOK) - Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati IGMS (IGM Biosciences)|iTeos Therapeutics Inc (ITOS) - Uzoq muddatli majburiyatlarning kapitalga nisbati|OCEA - Uzoq muddatli qarzning o'z kapitaliga nisbati|TCBP (TC BioPharm Ltd) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|THRD (Third Harmonic Bio) - Uzoq muddatli qarzning o'z kapitaliga nisbati